1. Home
  2. SRPT vs TXG Comparison

SRPT vs TXG Comparison

Compare SRPT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$18.83

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$19.08

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRPT
TXG
Founded
1980
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
SRPT
TXG
Price
$18.83
$19.08
Analyst Decision
Hold
Hold
Analyst Count
28
14
Target Price
$25.76
$16.82
AVG Volume (30 Days)
2.3M
2.5M
Earning Date
04-17-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
140.34
76.97
EPS
N/A
N/A
Revenue
$1,901,979,000.00
$245,893,000.00
Revenue This Year
$14.67
N/A
Revenue Next Year
N/A
$7.32
P/E Ratio
N/A
N/A
Revenue Growth
52.97
68.06
52 Week Low
$10.42
$6.78
52 Week High
$109.55
$23.56

Technical Indicators

Market Signals
Indicator
SRPT
TXG
Relative Strength Index (RSI) 43.14 51.38
Support Level $17.45 $17.26
Resistance Level $18.70 $19.78
Average True Range (ATR) 1.00 1.31
MACD -0.01 -0.07
Stochastic Oscillator 37.11 61.02

Price Performance

Historical Comparison
SRPT
TXG

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: